The Autophagy Pathway: A Critical Route in the Disposal of Alpha 1-Antitrypsin Aggregates That Holds Many Mysteries

Int J Mol Sci. 2021 Feb 13;22(4):1875. doi: 10.3390/ijms22041875.

Abstract

The maintenance of proteome homeostasis, or proteostasis, is crucial for preserving cellular functions and for cellular adaptation to environmental challenges and changes in physiological conditions. The capacity of cells to maintain proteostasis requires precise control and coordination of protein synthesis, folding, conformational maintenance, and clearance. Thus, protein degradation by the ubiquitin-proteasome system (UPS) or the autophagy-lysosomal system plays an essential role in cellular functions. However, failure of the UPS or the autophagic process can lead to the development of various diseases (aging-associated diseases, cancer), thus both these pathways have become attractive targets in the treatment of protein conformational diseases, such as alpha 1-antitrypsin deficiency (AATD). The Z alpha 1-antitrypsin (Z-AAT) misfolded variant of the serine protease alpha 1-antitrypsin (AAT) is caused by a structural change that predisposes it to protein aggregation and dramatic accumulation in the form of inclusion bodies within liver hepatocytes. This can lead to clinically significant liver disease requiring liver transplantation in childhood or adulthood. Treatment of mice with autophagy enhancers was found to reduce hepatic Z-AAT aggregate levels and protect them from AATD hepatotoxicity. To date, liver transplantation is the only curative therapeutic option for patients with AATD-mediated liver disease. Therefore, the development and discovery of new therapeutic approaches to delay or overcome disease progression is a top priority. Herein, we review AATD-mediated liver disease and the overall process of autophagy. We highlight the role of this system in the regulation of Z-variant degradation and its implication in AATD-medicated liver disease, including some open questions that remain challenges in the field and require further elucidation. Finally, we discuss how manipulation of autophagy could provide multiple routes of therapeutic benefit in AATD-mediated liver disease.

Keywords: Z aggregates; alpha-1 antitrypsin deficiency; autophagy; clearance; proteostasis; ubiquitin–proteasome system (UPS).

Publication types

  • Review

MeSH terms

  • Autophagy*
  • Hepatocytes* / metabolism
  • Hepatocytes* / pathology
  • Humans
  • Inclusion Bodies / genetics
  • Inclusion Bodies / metabolism
  • Inclusion Bodies / pathology
  • Liver Diseases* / metabolism
  • Liver Diseases* / pathology
  • Liver Diseases* / surgery
  • Liver Transplantation*
  • Liver* / metabolism
  • Liver* / pathology
  • Protein Aggregation, Pathological* / genetics
  • Protein Aggregation, Pathological* / metabolism
  • Protein Aggregation, Pathological* / pathology
  • Protein Aggregation, Pathological* / surgery
  • alpha 1-Antitrypsin Deficiency / genetics
  • alpha 1-Antitrypsin Deficiency / metabolism
  • alpha 1-Antitrypsin Deficiency / pathology
  • alpha 1-Antitrypsin* / genetics
  • alpha 1-Antitrypsin* / metabolism

Substances

  • SERPINA1 protein, human
  • alpha 1-Antitrypsin